Börsipäev 4. oktoober

mingi lühiajaline põrge võib NTRI'st tulla sellise short interesti peale
kuid MT jääb tõenäoliselt siia loksuma
nojah, mis tasemelt seda põrget mõõtma hakata?! Või milline on õige tase ostmiseks? Praegu on stock juba tunduvalt madalamal eilsest järelturust ning oleks eelturul ostma hakanud põrkemänguna, oleksid praegu vee all. NTRIle omaselt kommentaare situatsiooni kohta ka täpsemalt ei jagata enne tulemusi, mis hirmutab kindlasti investoreid. Praegu tundub suht broken ja huvi ei ole eriti tekkinud. Agressiivsed tgt cutid ka...

Nutrisystem downgraded to Hold at Kaufman- tgt cut to $40 from $90
Nutrisystem downgraded to Buy at Broadpoint Capital- tgt cut to $50 from $75

aga eks millalgi ikka põrkab jah : )

jah, see põrge võib kuskilt altpoolt tulla
dead on ta mõneks ajaks nii ehk naa
for the record - ei mängi põrget
ja positsiooni kohta otsus veel tegemata
NTRI puhul on alles 31-32$ tase kust tasub põrget oodata. Esiteks on see oluline Fibonacci tase ja teiseks toimus seal 2005 lõpp/2006 algus konsolideerumine.

Saksamaa DAX -0.05%

Prantsusmaa CAC 40 +0.11%

Inglismaa FTSE 100 +0.69%

Hispaania IBEX -0.06%

Venemaa RTS -0.15%

Poola WIG +0.29%

Aasia turud:

Jaapani Nikkei 225 -0.62%

Hong Kongi Hang Seng N/A -1.84%

Hiina Shanghai A (kodumaine) +2.65%

Hiina Shanghai B (välismaine) +1.44%

Lõuna-Korea Kosdaq +0.54%

Tai Set -0.26%

India Sensex -0.39%

USA turgudel positiivsed meeleolud ning oleme avanemas ca 0.2-0.3% plusspoolel.

Don't Buck the Trend
By Rev Shark
RealMoney.com Contributor
10/4/2007 8:35 AM EDT


Trends, like horses, are easier to ride in the direction they are going.
-- John Naisbitt

When a market has rallied as furiously as this one has since mid-August, there can be a great temptation to try to determine when the uptrend might finally end. It is a particularly hard temptation to avoid in the present situation, since there seems to be so many macroeconomic negatives that are seemingly at odds with a strong market.

The market is obviously acting very well, but we all know that there are concerns that the economy will slow in the near future. What could be more logical or appealing than trying to guess at what point those worries and concerns may actually kick in and end this strong uptrend?

The problem with that approach is that it is just so darn hard to do. There is no way to logically conclude when buyers are finally going to relent. The problem is that buyers are driven mainly by emotions. The majority don't buy because they think stocks are cheap or that the weak dollar is going to boost earnings of multinationals. Those might be justifications they use for their actions, but most buyers buy because they see things going up and don't want to be left behind while others are making money.

The market is an exercise in crowd psychology. Investors want to run with the herd. Eventually the herd will go too far and things will reverse, but it is extremely easy to underestimate the persistence of herd behavior, Stocks always go higher or lower than seems reasonable. If you try to apply cold, hard logic to emotional behavior you are very likely to be disappointed.

Rather than being overly anticipatory about when the market trend may finally end, the better approach is to be reactive as things develop. When the market eventually starts to top, there will be signs that will tip us off that a change is taking place. The dip-buyers will begin to lose their enthusiasm, the momentum players will stop chasing as vigorously, breakouts will fail to hold and the character of the action in individual stocks will start to change. Many of the warning signs of a trend change are subtle, but if you stay vigilant, you can begin to spot them and start to adjust your market posture.

For now, the trend remains solidly up and there are few signs that it is ready to end. The profit-taking yesterday looked like simple consolidation within an uptrend. It may develop into something more dire, but we don't have any major indications of that right now.

The most likely catalyst for a change in market trend, if one is going to occur, is the upcoming earnings reports for the third quarter. That news will provide very clear excuses for buying or selling and is likely to determine whether the trend continues.

Until earnings hit, we are likely to stay in a choppy trading range with a somewhat positive bias. It is certainly premature to anticipate a market breakdown, but it is never too early to watch for signs of one.

We have a slightly positive open shaping up. Asian markets were mostly negative while Europe was slightly positive as interest rates were left unchanged by the ECB.
-----------------------------
Ülespoole avanevad:

Chinese momentum names moving higher again in pre-mkt, despite a second down day in Hong Kong trading (Hang Seng -1.8%): GAI +16.6%, RCH +15.7%, NOEC +10.4%, CHNR +9.6%, CHINA +8.9%, GRRF +8.0%, CSUN +7.5%, WX +6.5%, TSTC +6.4%, HIHO +6.3%, EFUT +5.7%, CDS +3.7%... Other news: HEPH +41.7% (announced new preclinical data demonstrated that HE3235 significantly inhibited tumor growth), TBUS +% (receives order from General Electric; Order for digital recorders products valued at approximately $1 mln), CTCT +8.5% (continued momentum after strong IPO opening yesterday), CKNN +7.5% (upgraded to Buy at ThinkEquity), ASTI +7.0% (US Air Force increases funding of ASTI's solar cell program), LDK +6.5% (co issued statement regarding recent allegations, which they believe have "no merit"; we're hearing stock was downgraded at CIBC as well), ATHN +5.7% (Cramer called ATHN the best of his overlooked IPO lot), SPF +5.1% (Upgraded to Neutral at UBS), ISIS +4.8% (reports positive results of Phase 2 study of ISIS 301012 in Heterozygous FH patients), HMY +4.0% (reports that the trapped miners S. Africa are being evacuated).

Allapoole avanevad:

On weak earnings/guidance: RNIN -27.6%, NTRI -24.3% (also downgraded at Broadpoint Capital and Kaufman), WTSLA -15.8% (also downgraded to Neutral at Cowen), ISLN -16.1% (also downgraded at RBC Capital and Caris & Co), ARM -7.1%, SMOD -6.5%, CNX -4.4... China stocks continue to see volatility, with mixed trading in individual names this morning after the Hang Seng index was down 1.8% (We note that a number of China stocks are gapping up as well): CRNT -5.1% (downgraded to Neutral at Oppenheimer), SSRX -5% (downgraded to Sector Perform at CIBC), YGE -4.2%, CEO -3%, LDK -3% (downgraded to Underperform at CIBC)... Other news: PPCO -28.1% (Endo and Penwest receive paragraph IV certification notice for OPANA ER), HANS -5% (downgraded to neutral at tier-1 firm), ISIL -1.4% (added to sell list at tier-1 firm).
Järgmine video peaks küll kõigile vandenõuteoreetikutele meeldima.

Debating whether or not Bob Rubin (citigroup) turned Ben Bernanke around on rate cuts, with Ken Thomas, Wharton School of Business, and CNBC's Larry Kudlow.

http://www.cnbc.com/id/15840232?video=542967673&play=1#
Nutrisystem drops another 2.50 at the open to new lows; now down over 30%
Nii, 31$ peaks algama NTRI põrge
Briefing.com tuletab täna meelde nn. "Dow teooriat", mille kohaselt Dow Industrials uued tipud peavad saama kinnitatud ka Dow Transports ja Dow Utilities indeksite poolt, vastupidine olukord viitab ületootmisele tööstuses ja ennustab Dow langust või siis peaksid Transports ja Utilities hoogsalt järgi võtma

Vaata graafikut
Toon Beari arvamuse ära, kes ootab Föderaalreservi intressimäärade edasisi langetamisi, kuigi vahemik on päris suur:

BSC Bear Stearns Mortgage Head says expects Fed to cut by 50 to 100 basis points over next three quarters
Tänaseks pole Dow Transports ja Dow Utilities küll erilist tõusmise märki näidata suutnud kui siis ehk viimane

The credit markets are more stable than they were in August, but problems with asset-backed securities still exist, said Dallas Federal Reserve President Richard Fisher. (Dow Jones)

RIMMi tulemused inline: RIMM prelim $0.50 vs $0.49 Reuters consensus; revs $1.37 bln vs $1.36 bln Reuters consensus.
Aktsia +4% pealt praegu -1% peale kukkunud.
Aga praeguseks juba kõrgemal plussis tagaisi
Co issues upside guidance for Q3, sees EPS of $0.59-0.63 vs. $0.55 consensus; sees Q3 revs of $1.60-1.67 bln vs. $1.52 bln consensus.